
Peptide Antibiotics Global Market Report 2025 Including: 1) By Type: Ribosomal Synthesized Peptide Antibiotics; Non-Ribosomal Synthesized Peptide Antibiotics 2) By Drugs: Daptomycin; Dalbavancin; Telavancin 3) By Disease Outlook: Skin Infection; HABP Or V
Description
Peptide Antibiotics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on peptide antibiotics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for peptide antibiotics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The peptide antibiotics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Type: Ribosomal Synthesized Peptide Antibiotics; Non-Ribosomal Synthesized Peptide Antibiotics
2) By Drugs: Daptomycin; Dalbavancin; Telavancin; Other Drugs
3) By Disease Outlook: Skin Infection; HABP Or VABP; Blood Stream Infection; Other Diseases
4) By Distribution Channel: Hospitals; Homecare; Specialty Clinics; Other Distribution Channels
Subsegments:
1) By Ribosomal Synthesized Peptide Antibiotics: Aminoglycosides; Macrolides; Tetracyclines; Lincosamides
2) By Non-Ribosomal Synthesized Peptide Antibiotics: Bacitracins; Vancomycin; Polymyxins; Cyclic Lipopeptides
Companies Mentioned: Eli Lilly and Company; GlaxoSmithKline plc; Novartis AG; Pfizer Inc.; Merck & Co. Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on peptide antibiotics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for peptide antibiotics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The peptide antibiotics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Type: Ribosomal Synthesized Peptide Antibiotics; Non-Ribosomal Synthesized Peptide Antibiotics
2) By Drugs: Daptomycin; Dalbavancin; Telavancin; Other Drugs
3) By Disease Outlook: Skin Infection; HABP Or VABP; Blood Stream Infection; Other Diseases
4) By Distribution Channel: Hospitals; Homecare; Specialty Clinics; Other Distribution Channels
Subsegments:
1) By Ribosomal Synthesized Peptide Antibiotics: Aminoglycosides; Macrolides; Tetracyclines; Lincosamides
2) By Non-Ribosomal Synthesized Peptide Antibiotics: Bacitracins; Vancomycin; Polymyxins; Cyclic Lipopeptides
Companies Mentioned: Eli Lilly and Company; GlaxoSmithKline plc; Novartis AG; Pfizer Inc.; Merck & Co. Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
200 Pages
- 1. Executive Summary
- 2. Peptide Antibiotics Market Characteristics
- 3. Peptide Antibiotics Market Trends And Strategies
- 4. Peptide Antibiotics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
- 5. Global Peptide Antibiotics Growth Analysis And Strategic Analysis Framework
- 5.1. Global Peptide Antibiotics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Peptide Antibiotics Market Growth Rate Analysis
- 5.4. Global Peptide Antibiotics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Peptide Antibiotics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Peptide Antibiotics Total Addressable Market (TAM)
- 6. Peptide Antibiotics Market Segmentation
- 6.1. Global Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Ribosomal Synthesized Peptide Antibiotics
- Non-rRibosomal Synthesized Peptide Antibiotics
- 6.2. Global Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Daptomycin
- Dalbavancin
- Telavancin
- Other Drugs
- 6.3. Global Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Skin Infection
- HABP/VABP
- Blood Stream Infection
- Other Diseases
- 6.4. Global Peptide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Homecare
- Specialty Clinics
- Other Distribution Channels
- 6.5. Global Peptide Antibiotics Market, Sub-Segmentation Of Ribosomal Synthesized Peptide Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Aminoglycosides
- Macrolides
- Tetracyclines
- Lincosamides
- 6.6. Global Peptide Antibiotics Market, Sub-Segmentation Of Non-Ribosomal Synthesized Peptide Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Bacitracins
- Vancomycin
- Polymyxins
- Cyclic Lipopeptides
- 7. Peptide Antibiotics Market Regional And Country Analysis
- 7.1. Global Peptide Antibiotics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Peptide Antibiotics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Peptide Antibiotics Market
- 8.1. Asia-Pacific Peptide Antibiotics Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Peptide Antibiotics Market
- 9.1. China Peptide Antibiotics Market Overview
- 9.2. China Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Peptide Antibiotics Market
- 10.1. India Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Peptide Antibiotics Market
- 11.1. Japan Peptide Antibiotics Market Overview
- 11.2. Japan Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Peptide Antibiotics Market
- 12.1. Australia Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Peptide Antibiotics Market
- 13.1. Indonesia Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Peptide Antibiotics Market
- 14.1. South Korea Peptide Antibiotics Market Overview
- 14.2. South Korea Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Peptide Antibiotics Market
- 15.1. Western Europe Peptide Antibiotics Market Overview
- 15.2. Western Europe Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Peptide Antibiotics Market
- 16.1. UK Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Peptide Antibiotics Market
- 17.1. Germany Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Peptide Antibiotics Market
- 18.1. France Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Peptide Antibiotics Market
- 19.1. Italy Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Peptide Antibiotics Market
- 20.1. Spain Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Peptide Antibiotics Market
- 21.1. Eastern Europe Peptide Antibiotics Market Overview
- 21.2. Eastern Europe Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Peptide Antibiotics Market
- 22.1. Russia Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Peptide Antibiotics Market
- 23.1. North America Peptide Antibiotics Market Overview
- 23.2. North America Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Peptide Antibiotics Market
- 24.1. USA Peptide Antibiotics Market Overview
- 24.2. USA Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Peptide Antibiotics Market
- 25.1. Canada Peptide Antibiotics Market Overview
- 25.2. Canada Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Peptide Antibiotics Market
- 26.1. South America Peptide Antibiotics Market Overview
- 26.2. South America Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Peptide Antibiotics Market
- 27.1. Brazil Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Peptide Antibiotics Market
- 28.1. Middle East Peptide Antibiotics Market Overview
- 28.2. Middle East Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Peptide Antibiotics Market
- 29.1. Africa Peptide Antibiotics Market Overview
- 29.2. Africa Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Peptide Antibiotics Market Competitive Landscape And Company Profiles
- 30.1. Peptide Antibiotics Market Competitive Landscape
- 30.2. Peptide Antibiotics Market Company Profiles
- 30.2.1. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 31. Peptide Antibiotics Market Other Major And Innovative Companies
- 31.1. AbbVie Inc.
- 31.2. Sandoz International GmbH
- 31.3. Xellia APS
- 31.4. Johnson & Johnson Inc.
- 31.5. AstraZeneca PLC
- 31.6. Bayer AG
- 31.7. Bristol-Myers Squibb Company
- 31.8. Lupin Pharmaceuticals Inc.
- 31.9. Sun Pharmaceutical Industries Ltd.
- 31.10. Teva Pharmaceutical Industries Ltd.
- 31.11. Torrent Pharmaceuticals Ltd.
- 31.12. Wockhardt Ltd.
- 31.13. Zydus Lifesciences Limited
- 31.14. Alkem Laboratories Limited
- 31.15. Allecra Therapeutics GmbH
- 32. Global Peptide Antibiotics Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Peptide Antibiotics Market
- 34. Recent Developments In The Peptide Antibiotics Market
- 35. Peptide Antibiotics Market High Potential Countries, Segments and Strategies
- 35.1 Peptide Antibiotics Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Peptide Antibiotics Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Peptide Antibiotics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.